Coronary artery diseases (CAD) are influenced by multiple genes of modest effect as the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism, related to MTHFR activity and total plasma homocysteine (tHcy) concentration. This study was designed to evaluate tHcy, oxidized low-density lipoprotein (LDL) (ox-LDL), high-sensibility C-reactive protein (Hs CRP) levels, and homocysteine thiolactonase (HTase) activities as new risk factors for CAD and to investigate an association between MTHFR polymorphism tHcy concentrations and coronary syndrome severity. Our results showed significantly higher levels of tHcy and ox-LDL in patients associated with lower HTase activities. These levels increased proportionally to disease severity. Total plasma Hcy levels were negatively correlated to HTase activities in patients where the TT genotype was significantly more frequent. In a multivariate analysis, tHcy level was the only independent factor affecting the coronary syndrome severity. High tHcy levels are associated with coronary syndrome severity and may be explained either by the elevated prevalence of TT genotype or by the diminished HTase activities.
Introduction
Mild hyperhomocysteinemia is an independent and graded risk factor for cerebral, peripheral, and coronary artery disease (CAD). 1 Elevated homocysteine (Hcy) concentrations may originate from nutritional deficiencies in cofactors or cosubstrates of enzymes involved in Hcy metabolism or from molecular defects in genes coding for enzymes crucial in this metabolism such as methylenetetrahydrofolate reductase (MTHFR). 2, 3 In 1988, Kang et al described a new MTHFR variant with thermolabile properties. 3 Individuals carrying this variant have decreased specific activity in lymphocytes (<50% of the control mean) and elevated plasma Hcy concentrations. 3 In fact a punctual substitution of a conserved alanine by a valine residue at position 677 pb in the MTHFR is responsible of this mutation. 4 Thermolabile MTHFR was found to be the cause of abnormal Hcy metabolism 5 and was also correlated to the severity of coronary syndrome. 6 Although the exact mechanism of Hcy toxicity is unknown, it is believed that Hcy or its metabolite adversely affects vascular endothelium inducing atherosclerosis. Several mechanisms may be included, Hcy is first converted by methionyl-transfer RNA synthetase to Hcy thiolactone, which then reacts with lysine residues in proteins, damaging their structure and impairing their physiological activities. 7 The extent of Hcy thiolactone synthesis and protein homocysteinylation in human vascular endothelial cells depend on the levels of Hcy, methionine, folate, and high-density lipoprotein (HDL), known to be linked to vascular disease. Human serum Hcy thiolactonase (HTase), a component of HDL, hydrolyzes Hcy thiolactone to Hcy. 8 Recent data also indicate that circulating levels of Hcy affect low-density lipoprotein (LDL) stability and increase its oxidability. Moreover, macrophage-rich plaques have been recently shown to contain higher concentration of oxidized LDL (ox-LDL) than macrophage-poor plaques 9, 10 and to be associated with elevated levels of ox-LDL in plasma. 9 Taken together, these evidences suggest that plasma and plaque levels of ox-LDL may be correlated with the vulnerability of atherosclerotic lesions to rupture.
The aim of this study was to evaluate Hcy, ox-LDL, highsensibility C-reactive protein (Hs CRP) levels and thiolactonase activities as new risk factors for CAD and to assess the role of MTHFR mutation in disease severity.
Materials and Methods

Study Population
The cohort consists of 122 patients with angiographically documented CAD. These patients (aged 59.9 + 12.1 years) presented a clinical history of stable angina pectoris (SAP), previous acute coronary syndromes with or without ST segment elevation. Three groups of patients were defined: SAP, unstable angina pectoris (UAP), and acute myocardial infarction (AMI). The diagnosis of AMI was based on a history of prolonged ischemic chest pain, characteristic electrocardiographic (ECG) changes, and elevated creatine kinase (2 times above normal range) within 24 hours after the onset of pain. Unstable angina pectoris was defined as new onset angina within 2 months after a previous bout; angina with a progressive crescendo pattern, with the anginal episodes increasing in frequency and/or duration; angina that occurred at rest; or angina occurring in the immediate postinfarct period. Stable angina pectoris was defined as chest pain typical of cardiac ischemia on exertion. The extent of CAD was assessed by the number of coronary vessels with more than 50% reduction in the luminal diameter 1, 2 or 3 vessels. These patients did not receive any antioxidant drugs. A total of 118 age-matched healthy volunteer blood donors served as controls (aged 61.2 + 9.6 years). Among the control participants, none had hypercholesterolemia or diabetes mellitus, none used antioxidant medication.
The following data were obtained: age, sex, and the presence of risk factors (cigarette, smoking, hypertension; diagnosed according to the JNC criteria [Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure]), diabetes mellitus (diagnosed and classified according to American Diabetes Association criteria [Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997]), dyslipidemia (defined as LDL-C > 2.6 mmol/L, low HDL-C [>1.03mmol/L in men and >1.29 mmol/L in women] and/or triglycerides > 1.7 mmol/L), and hypercholesterolemia (defined as a cholesterol level 5.68 mmol/L, a triglyceride concentration 2.28 mmol/L) or when receiving a lipid-lowering drug. Weight and height were measured using a standard scale and waist-to-hip ratio (WHR) was calculated. Body mass index (BMI) was calculated from the equation: BMI ¼ weight/ height 2 (kg/m 2 ). This study was approved by our hospital ethical committee, and informed consent was obtained from all patients before their enrollment. Major requirements for enrollment in all the groups were absence of infectious or acute/chronic inflammatory diseases, known malignancy, absence of acute/chronic renal failure, or hepatic failure.
Laboratory Analyses
Blood samples were drawn, following overnight fasting, into tubes containing EDTA and plasma was immediately separated by centrifugation. Plasma levels of total cholesterol, HDL-C and LDL-C cholesterol, total plasma Hcy levels (tHcy), and homocysteine thiolactonase activity (HTase) were measured in the group of patients and in the control participants, according to validated laboratory procedures. 11 Measurements of apolipoproteins A and B: apo A-I and apo B concentrations were performed using an immunoturbidimetric method as described by Smaoui et al. 12 Oxidized LDL levels (ox-LDL) were measured by a sandwich enzyme-linked immunosorbent assay (ELISA) method using a commercial kit (ox-LDL ELISA Kit; Immunodiagnostic Bensheim, Germany). 13 High-sensibility CRP levels were determined using an immunonephelometric method (Behring N Latex C-Reactive Proteine Mono-Analyzer; Behring Diagnostic, Marburg, Germany).
Methylenetetrahydrofolate Reductase Genotyping
The genotyping of MTHFR was performed as described previously. 13 In brief, genomic DNA was extracted from peripheral blood lymphocytes using a salting out DNA extraction method, and mutation analysis was performed essentially as described by Frosst et al. 4 Electrophoresis in a 2% agarose gel followed by ethidium bromide staining and UV illumination allowed detection of mutated alleles.
Statistical Analysis
Statistical analyses were assessed using the Statistical Package for Social Sciences (SPSS Inc, Chicago, Illinois). Data are presented as median (25th-75th interquartile range) for several variables that were not normally distributed. Comparison between the 2 groups was performed with the Mann-Whitney U test, and the Kruskal-Wallis 1-way analysis of variance test was used to compare between more than 2 groups. The Spearman rank correlation (rs) was used to test the association between the variables. To determine whether tHcy, ox-LDL or HTase activities are independently associated with the severity of CAD, binary logistic regression analysis, which allows adjustment for confounding factors, was performed. Coronary artery disease was used as the dependent variable and included known CAD risk factors as potential confounders. Values of P < .05 were considered statistically significant. Table 1 summarizes the anthropometric and metabolic information obtained from the patients and the healthy participants in this study. The BMI was 10% higher in the patient groups as compared to the healthy one, they also have higher WHR. Although the median of triglyceride, the mean of total cholesterol and apo B were significantly higher in coronary syndrome patients than in the controls, the mean of HDL-C was significantly lower. Compared with the controls, tHcy levels were significantly increased by 25% (P ¼ .00), serum HTase activity was significantly reduced by 44% (P ¼ .00), and levels of ox-LDL significantly increased by 47 % (P ¼ .00) in the patients.
Results
Characteristics of the Studied Population
Evaluations of the Risk Factors
As far as the risk factors were considered in the 3 groups of patients, we found that male gender and smoking are risk factors for myocardial infarction. When we considered the lipid parameters, we found significantly lower levels of apo AI associated to lower HDL-C levels in the AMI group. Significantly higher apo B levels associated with higher LDL-C levels were surprisingly found in the SAP group patients ( Table 2 ). We also evaluated some inflammatory markers according to disease severity, and we found that the white blood cells were high in the AMI group associated to significantly increased levels of Hs CRP. Oxidized LDL levels were also increased according to disease severity (174.2 for the AMI group vs 132.7 and 135.2 ng/mL for the UAP and SAP groups, respectively). Concerning tHcy levels, they were significantly higher in the AMI group associated with significantly low HTase activities. In fact, a negative correlation between tHcy levels and HTase activities was found in the group of coronary syndrome patients ( Figure  1 ). Spearman correlation rank was then used to evaluate the correlations between tHcy levels and HTase activities and Hs CRP levels and some lipid parameters in the patients. Total plasma Hcy levels were positively correlated to Hs CRP levels (r ¼ .289, P ¼ .00).
The distribution of MTHFR polymorphism in CAD patients and controls is shown in Table 4 . The observed frequencies of MTHFR genotypes were comparable to those previously reported in the Tunisian population and were in Hardy-Weinberg equilibrium in both groups. The overall frequency for the (T) allele was 33% among patients with CAD and 22.85% among control participants. The numbers of individuals homozygous for the 677C>T transition were 20 (16.5%) of 122 patients with CAD versus 9 (7.6%) of 118 controls (P < .05). In our population, we found that the mutant TT genotype frequency was lower than Western European populations 14 but higher than Turkish population 15 either in the controls or the CAD patient groups ( Table 4 ). The association of the different genotypes with the incidence of CAD was tested, and we showed that the prevalence of TT genotype was significantly higher in the CAD group (OR ¼ 2.39, CI 95% ¼ 0.92-6.28, P ¼ .046).
The effect of the MTHFR gene polymorphism on tHcy levels was then evaluated in each group of patient according to disease activity (Figure 2 ). TT genotype was associated with the higher tHcy levels in the different groups. The highest 
Discussion
Increased levels of oxidative stress, as in states of dyslipidemia, aging, and smoking, have been associated with CAD. Homocysteine have also been involved in oxidative stress, oxidation and peroxidation of lipids, smooth muscle cell proliferation, hypercoagulability, and endothelial dysfunction. [16] [17] [18] Cardiovascular diseases are common, multifactorial disorders likely to be influenced by multiple genes of modest effect. The C677T MTHFR gene polymorphism is related to MTHFR enzyme activity and to plasma Hcy concentration. This study was designed to investigate an association between new cardiovascular risk factor: HTase activities Hs CRP, ox-LDL, and MTHFR polymorphism with CAD severity. Advanced coronary atherosclerosis is known to be the final event of a multifactorial process involving many interactions among numerous risk factors, whereas other factors such as hyperhomocysteinemia are still a matter of investigation. As the conventional risk factors were concerned, our current study showed a marked dyslipidemia in the patients with CAD, associated to significantly decreased apo B levels. The role of apo B as an important risk factor for coronary syndrome is biologically plausible, 19, 20 because plasma apo B concentrations reflect the number of atherogenic lipoprotein particles. 21 The atherogenic lipoproteins including LDL, and chylomicron remnants contain variable amounts of triglycerides and cholesterol, but each of these particles contain 1 molecule of apo B as structural protein. Due to the heterogeneity of lipoprotein particle composition, apo B is superior to cholesterol and triglycerides as a coronary syndrome risk factor. In opposite apo B levels were not a good predictor of coronary syndrome severity.
The relationship between elevated Hcy concentrations and an increased risk of atherosclerotic vascular disease was explored by several studies. 2, [22] [23] [24] [25] [26] [27] Evidence was then given by a meta-analysis 1 that elevations in Hcy concentrations have to be considered an independent and graded risk factor for different categories of arterial occlusive diseases. In fact, an increment of 5 mmol/L in tHcy elevates the risk of CAD as much as an increase of 0.5 mmol/L of total cholesterol. 1 In this study, tHcy levels were significantly higher in the patients with coronary syndrome, associated with elevated levels of ox-LDL and Hs CRP but lower thiolactonase activities. These levels increased accordingly to the severity of the coronary syndrome. In addition our current data support the concept that, in addition to the well-accepted inverse correlation between paraoxonase activity and incidence of coronary syndrome, the HTase activity of HDL may be another important independent antiatherogenic property that negatively correlates with the severity of coronary syndrome. The MTHFR gene is found to be associated with increased cardiovascular risk in several populations including Lebanese, Japanese, and French Canadians, 4, [27] [28] [29] whereas no association between MTHFR C677T mutation and coronary syndrome could be demonstrated in other studies. [30] [31] [32] [33] [34] Mutations in the MTHFR gene could reduce its enzymatic activity and cause hyperhomocysteinemia, as well as vascular complications including CAD. 3, 5, 6, 35, 36 The MTHFR mutation is associated with mild or moderately elevated Hcy levels: a 12% increase in the heterozygous state and a 30% in the homozygous state. These findings correlate well with our results where homozygous (TT) and even heterozygous (CT) individuals exhibited significantly elevated Hcy levels compared with (CC) individuals. Furthermore, we demonstrated the significance of the homozygous (TT) genotype as a risk factor for coronary syndrome.
In conclusion, our results indicate that plasma Hcy levels, ox-LDL, Hs CRP, and decreased HTase activities are good predictors of coronary syndrome severity. The TT genotype of the C677T MTHFR polymorphism is associated with CAD in the Tunisian patients. In addition, TT genotype carriers had higher plasma Hcy levels in patients compared with CC and CT genotypes. We also found that the MTHFR gene polymorphism could be good predictor of coronary syndrome severity. These findings require further investigations in large populationbased studies. Based on all these findings, clinical intervention would be an effective goal for the treatment of coronary syndrome patients to restore their impaired antiatherogenic activity of HDL particles.
